Comparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal mice

被引:14
|
作者
Sasu, BJ [1 ]
Hartley, C [1 ]
Schultz, H [1 ]
McElroy, P [1 ]
Khaja, R [1 ]
Elliott, S [1 ]
Egrie, JC [1 ]
Browne, JK [1 ]
Begley, CG [1 ]
Molineux, G [1 ]
机构
[1] Amgen Inc, Dept Hematol, Thousand Oaks, CA 91320 USA
关键词
Aranesp (R); darbepoetin alfa; epoetin alfa; erythropoietic units; hemoglobin;
D O I
10.1159/000084446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The unit of erythropoietic activity has long been the standard by which erythropoietic agents are judged, but the development of long-acting agents such as darbepoetin alfa has highlighted the shortcomings of this approach. To this point, we compared the in vivo activity of Epoetin alfa and darbepoetin alfa per microgram of protein core. Using the established mass-to-unit conversion for Epoetin alfa (1 mu g congruent to 200 U), we then calculated darbepoetin alfa activity in units. Activity varied with treatment regimen (1 mu g darbepoetin alfa congruent to 800 U for 3 times weekly dosing to 8,000 U for a single injection). This analysis reveals the inadequacy of evaluating darbepoetin alfa activity in terms of standard erythropoietic units. We therefore propose that for molecules with heightened biological activity, a more legitimate basis for comparison is the protein mass. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [11] The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa.
    Song, Xue
    Long, Stacey R.
    Marder, William D.
    Sullivan, Sean D.
    Kallich, Joel
    BLOOD, 2008, 112 (11) : 469 - 470
  • [12] Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure
    Kanbay, Mehmet
    Akcay, Ali
    Delibasi, Tuncay
    Uz, Burak
    Kaya, Arif
    Koca, Cemile
    Turgut, Faruk
    Bavbek, Nuket
    Uz, Ebru
    Duranay, Murat
    Yigitoglu, Ramazan
    ADVANCES IN THERAPY, 2007, 24 (02) : 346 - 352
  • [13] Comment: The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa REPLY
    Song, Xue
    Long, Stacey R.
    Marder, William D.
    Sullivan, Sean D.
    Kallich, Joel
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 595 - 596
  • [14] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
    Fahrbach, KR
    Frame, D
    Scheye, R
    Fastenau, JM
    Drielick, M
    Piech, CT
    Nalysnyk, L
    BLOOD, 2003, 102 (11) : 510B - 511B
  • [15] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy"
    Nowrousian, Mohammad Resa
    ONCOLOGIST, 2006, 11 (05): : 535 - 536
  • [16] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CANCER INPATIENTS RECEIVING CHEMOTHERAPY
    Vekeman, F.
    Bailey, R.
    Lafeuille, M. H.
    McKenzie, R. S.
    Herrera, A. D.
    Lefebvre, P.
    VALUE IN HEALTH, 2009, 12 (03) : A40 - A41
  • [17] Comparison of Epoetin Alfa and Darbepoetin Alfa Dosing and Costs in an Inpatient Population with Myelodysplastic Syndromes.
    Lafeuille, Marie-Helene
    Vekeman, Francis
    Bailey, Robert A.
    McKenzie, R. Scott
    Lefebvre, Patrick
    BLOOD, 2008, 112 (11) : 469 - 469
  • [18] Comparison of darbepoetin alfa and epoetin alfa for radiotherapy(RT) or chemoradiotherapy(CT/RT)-induced anemia
    Sampe, P
    Vallejo, C
    Lopez-Carrizosa, C
    Rodriguez, A
    Suez, J
    Delgado, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S479 - S479
  • [19] First comparison of biosimilar epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-induced anaemia
    Lorenz, A.
    Heine, O.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S295 - S295
  • [20] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy" - In Reply
    Waltzman, Roger
    ONCOLOGIST, 2006, 11 (05): : 536 - 537